P1047: REAL-WORLD SAFETY OF RUXOLITINIB IN PATIENTS WITH INTERMEDIATE OR HIGH RISK OF PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA MYELOFIBROSIS OR POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS IN CHINA

Bibliographic Details
Main Authors:	Z. Xu, M. Duan, Q. Jiang, Q. Leng, N. Xu, Y. Zhang, C. Zhao, W. Wu, Q. Zhang, J. Fu, J. Zhang, R. Fu, Z. Yan, C. Lin, G. Ouyang, Z. Wang, L. Ma, H. Hao, X. Li, S. Ran, Y. Chen, T. Li, Z. Xiao
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000847056.62279.a3

Internet